Combined therapy with SGLT2i and GLP-1ra improves cardiovascular prognosis in a population with diabetes and overweigh or obesity. A real-world clinical practice study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by